| Abstract P007 – Table 1. PrEP use characteristics and HIV incidence in Poland 2017‐2021. | ||||||
|---|---|---|---|---|---|---|
| 10 to 12 2017 | 2018 | 2019 | 2020 | 2021 | 2017 to 2021 | |
| PrEP users at PrEP clinics, n | 102 | 1128 | 2033 | 2684 | 3675 | NA |
| PrEP users outside of PrEP clinics, n | NA | NA | 394 | NA | NA | NA |
| Total estimated PrEP users, n | 102 | 1128 | 2427 | 3220 | 4410 | NA |
| MSM PrEP users, % | NA | NA | NA | NA | NA | 99 |
| HTX PrEP users, % | NA | NA | NA | NA | NA | 1 |
| On‐demand PrEP users, % | 2 | 15 | 20 | 17 | 35 | NA |
| HIV incidence among MSM at VCTs in Poland, /100PY | NA | NA | 4.3 | 3.4 | 3.7 | 3.8 |
HTX, heterosexual; PrEP, pre‐exposure prophylaxis; VCT, voluntary counselling and testing site.